We hypothesized that vascular nitric oxide synthase (NOS) function and expression is 25 differentially regulated in adult Dahl S rats maintained on Teklad or AIN-76A standard chow 26 diets from 3 to 16 weeks old. At 16 weeks old, acetylcholine (ACh)-mediated vasorelaxation 27 and phenylephrine (PE)-mediated vasoconstriction in the presence and absence of nitric oxide 28 synthase (NOS) inhibitor, L-NAME, was assessed in small resistance mesenteric arteries and 29 aortae. Rats maintained on either diet throughout the study had similar responses to ACh and 30 PE in the presence or absence of L-NAME in both vascular preparations. We reasoned that 31 changing from one diet to another as adults may induce vascular NOS dysfunction. In the 32 absence of L-NAME, small arteries from Teklad-fed rats switched to AIN-76 diet and vice versa 33 had similar responses to ACh and PE. Small arterial NOS function was maintained in rats 34 switched to AIN-76A from Teklad diet. Whereas, NOS function in response to ACh and PE was 35 lost in the small arteries from rats changed to Teklad from AIN-76A diet. This loss of NOS 36 function was echoed by reduced expression of NOS3 as well as phosphorylated NOS3. The 37 change in NOS phenotype in the small arteries was observed without changes in blood 38 pressure. Aortic responses to ACh or PE in the presence or absence of L-NAME were similar 39 in all diet groups. These data indicate that changing standard chow diets leads to small arterial 40 NOS dysfunction and reduced NOS signaling predisposing Dahl S rats to vascular disease. 41 42
Introduction 45
The nitric oxide synthase (NOS) pathway plays an obligatory role in vascular tone 46 homeostasis (1). Loss of NOS signaling results in a loss of tonic vasorelaxation favoring 47 greater vasoconstriction (11, 26, 42) and is linked to increased risk of vascular disease (3, 20, 48 43) . Humans that present increased blood pressure to salt have a greater disposition to 49 vascular disease risk even under normotensive conditions (44, 45) . A prototypical model to 50 study vascular dysfunction is the Dahl salt-sensitive (Dahl S) rat. In this rat strain, a high-salt 51 diet induces robust hypertension and vascular dysfunction (5, 6, 14, 25, 28, 32, 37) . 52
Intriguingly under normotensive conditions without high-salt diet, Dahl S rats have lower 53 vascular NOS expression (30) and greater blood pressure responsiveness to bolus doses of 54 phenylephrine (PE; α 1 -specific agonist) compared to the genetic salt-resistant control strain 55 (10). These data suggest that a genetic predisposition to salt-sensitivity per se, not frank 56 hypertension, enhances vascular disease risk. 57
Our laboratory is interested in understanding mechanisms that predispose salt-sensitive 58 individuals to vascular disease using the Dahl S model. Previous investigations showed that 59 promotion of salt-sensitive hypertension in adult Dahl S rats is dependent on the type of 60 weaning diet (27) . This led us to investigate whether vascular NOS function and expression 61 are sensitive to the choice of standard chow diets. The two popular commercial suppliers of 62 Dahl S rats, Harlan Laboratories (www.harlan.com) and Charles River Laboratories 63 (www.criver.com), each maintains their Dahl S colonies on different commercially-available 64 standard chows. Harlan uses Teklad diet and Charles River utilizes American Institutes of 65 Nutrition (AIN) purified diet. The standard chow at many institutions is Teklad diet; therefore, 66 some experimental designs would incorporate changing the standard chow diet during 67 adulthood once the rats are housed at the investigator's institution. We reasoned that changing 68 between standard chow diets may differentially regulate vascular NOS function. Thus, we 69 designed experiments to test the hypothesis that vascular NOS function and expression are 70 differentially regulated in adult Dahl S rats on Teklad 8604 or AIN-76A standard chow diets. 71
For this purpose, a colony of Dahl S rats was generated at Georgia Health Sciences University 72 to maintain a comparable stable environment. Male offspring were weaned on Teklad 8604 or 73 AIN-76A standard chow diet and were either maintained on the same weaning diet or switched 74 to the other standard chow diet at 12 weeks old. Mesenteric arterial and aortic reactivity as well 75
as NOS function and expression were assessed at 16 weeks old. 76 77 mEq/24h. Urinary total protein excretion was quantified using standard protein assay (BCA 115 assay, Bio-Rad; Hercules, CA). 116
Vascular Reactivity 117
Thoracic aortae and third-order mesenteric arteries were cleaned of adherent fat and 118 cut into concentric rings and mounted on pins and chucks, respectively, for wire myography 119 (Danish Myo Technology A/S; Aarhus, Denmark) as previously described (24). Aortic and 120 small mesenteric artery segments were constricted with 1 μM and 2 μM phenylephrine (PE), vasoconstrictor -baseline prior to constriction)/baseline prior to constriction) X 100. Rings 131 were incubated in the presence or absence of the non-specific NOS inhibitor Nω-Nitro-L-132 arginine methyl ester (L-NAME; 100µM; Sigma) for 15 minutes prior to construction of 133 response curves. Maximum response and sensitivity to the vasoactive agonists are expressed 134 as E max and logEC 50 , respectively. LogEC 50 was determined with GraphPad Prism software (La 135 Jolla, CA). 136
Western Blotting 137
In a subset of rats from each diet group, whole mesenteric arterial beds were 138 homogenized in 400μl ice-cold lysis buffer (50 mM Tris, 0.1 mM EDTA disodium salt, 0.1 mM 139 EGTA, 0.1 mM sucrose, 0.1% BME, 10% glycerol, 2 μM leupeptin, 2 μM pepstatin A, 1mM 140 phenylmethylsulfonyl fluoride, 0.1% aprotinin; 20 mM NaVO 3 ; pH 7.4); PhosSTOP tablets 141 were used according to manufacturer's instructions (Roche Diagnostics; Indianapolis, IN) . 142
Homogenates were spun at 10,000 rpm at 4°C for 5 minutes and supernatants isolated. 143
Protein concentrations of supernatants were determined (BCA assay, Bio-Rad). 30 μg of 144 protein was separated via 8% SDS-PAGE, transferred to PVDF membranes, and probed using 145 anti-NOS1, anti-NOS3, anti-NOS3-phosphoserine1177 (all NOS antibodies at 1:500; BD 146
Biosciences; San Jose, CA), and β-actin (1:10,000; Sigma). NOS antibodies were visualized 147 with goat anti-mouse (1:1000; Invitrogen; Carlsbad, CA) and β-actin detected with goat anti-148 rabbit (1:10,000; Invitrogen) secondary antibodies using the Odyssey Infrared Imaging System 149 (LI-COR Biosciences; Lincoln, NE). Analysis of NOS expression was normalized to β-actin. 150
Further analysis of NOS3-phosphoserine1177 was normalized to NOS3 expression. 151
Plasma nitrite/nitrate measurement 152
Plasma was extracted using 1:1 (v:v) HPLC-grade methanol (Fisher Scientific, Fair 153 Lawn, NJ) followed by centrifugation at 10,000 x g for 5 minutes at 4°C to evaluate nitrite and 154 nitrate levels by HPLC (ENO-20; EiCom Corporation, Kyoto, Japan) as previously described 155 (17). 156
Statistical Analyses 157
All data are expressed as mean ± standard error. Statistical significance was defined as 158 P<0.05 as determined by Student's t-test or two-way ANOVA where indicated (GraphPad 159 Prism). 160 Figure 1A shows the experimental design and nomenclature utilized for the study. Dahl 164 S rats fed either Teklad or AIN standard chow diets from 3 weeks until 16 weeks old gained 165 weight similarly and had comparable tibia lengths demonstrating that neither standard diet 166 differentially affected rat growth ( Figure 1B ; Table 1 ). Food and water intakes were also similar 167 at 16 weeks old (Table 1) . Heart weight and epididymal fat mass were similar in all diet groups 168 (Table 1) ; however, kidney weights were significantly smaller in the groups raised on the AIN 169 diet versus the Teklad with no difference between the other groups ( water intake was observed at 16 weeks old between the 4 diet groups (Table 1) . 175 176
161

Results
162
Metabolic Parameters 163
Hemodynamic and activity measurements 177
At 16 weeks old, 24h MAP and heart rate were similar in the non-switched weaning diet 178 groups (Teklad or AIN); the trend for increased 24h MAP in the diet-switch groups 179 (Teklad→AIN or AIN→Teklad) was not significant (Figure 2A ). Additionally, the tendency for 180 24h MAP to increase from 12 weeks old to 16 weeks old was not statistically different between 181 the 4 diet groups (Figure 2A ). At 16 weeks old, 24h heart rate was similar in all diet groups 182 ( Figure 2B ). Circadian rhythms of 12h MAP ( Figure 2C ) and heart rate ( Figure 2D ) were similar 183 during the last 3 days of the diet-switch protocol (at 15 weeks, 5 and 6 days old and at 16 184 weeks old). 185
186
Vasorelaxation 187
Cumulative-concentration response curves to acetylcholine (ACh) were generated to 188 assess endothelial function in third-order small resistance mesenteric arteries and thoracic 189 aortae. No difference in maximum relaxation (E max , Table 2 ) or sensitivity (logEC 50 , Table 2 ) 190 was detected between weaning diet groups or diet switch groups in small mesenteric arteries 191 as well as the response to the exogenous NO donor, SNP, between all 4 groups of Dahl S rats 192 (Table 2) . 193 To assess NOS function, ACh-mediated relaxation curves were generated in the 194 presence of the non-specific NOS inhibitor, L-NAME. L-NAME significantly reduced sensitivity 195
to ACh in Teklad ( Figure 3A ; Table 2 ), AIN ( Figure 3B ; Table 2 ), and Teklad→AIN ( Figure 3C ; 196 Table 2 ) diet groups; however, the trend for L-NAME pretreatment to reduce ACh sensitivity in 197 mesenteric artery segments from AIN→Teklad Dahl S rats was not statistically significant 198 ( Figure 3D ; Table 2 ). 199
Aortic vasorelaxation to ACh and SNP was similar in all 4 diet groups and L-NAME 200 totally blocked the ACh response (Table 3) . 201
202
Vasoconstriction 203
Cumulative-concentration response curves to PE were used to assess vasoconstriction 204 in third-order mesenteric arteries. PE-induced vasoconstriction was similar in all 4 diet groups 205 (Table 4 ). In addition, KCl-induced vasoconstriction was similar in mesenteric arteries isolated 206 from Teklad-fed, AIN-fed, and Teklad→AIN Dahl S rat diet groups (Table 4) . However, the KCl 207 response was significantly less in AIN versus all other diet groups (Table 4) . 208 L-NAME pretreatment significantly increased sensitivity to PE-induced constriction in 209 mesenteric arteries isolated from Teklad-fed ( Figure 4A ; Table 4), AIN-fed ( Figure 4B ; Table  210 4), and Teklad→AIN ( Figure 4C ; Table 4 ) Dahl S rats. Whereas, L-NAME had no significant 211 effect on the PE-induced vasoconstriction of mesenteric arteries from AIN→Teklad Dahl S rats 212 ( Figure 4D ; Table 4) . 213
Aortic response to PE and KCl was similar in all 4 diet groups (Table 5 ). L-NAME had 214 no significant effect on aortic response to PE in any of the 4 diet groups (Table 5) . 215
216
NOS protein expression 217
NOS3 protein expression was significantly reduced in small mesenteric arteries from 218 AIN and Teklad→AIN compared to Teklad ( Figure 5A and 5B). Moreover, NOS3 protein 219 expression was further reduced in small mesenteric arteries from AIN→Teklad compared to 220 AIN ( Figure 5A and 5B). The NOS3-p1177 expression ( Figure 5C and 5D) was similar in small 221 mesenteric arteries from Teklad and AIN. NOS3-p1177 expression in arteries from 222 Nitrite levels were similar in all 4 diet groups ( Figure 5E ). Moreover, nitrate levels were 229 similar in non-switched weaning diet groups ( Figure 5F ). Interestingly, nitrate levels were 230 increased following the Teklad→AIN diet switch whereas no change was detected in the 231
AIN→Teklad diet-switch group ( Figure 5F ). Our laboratory is interested in determining the mechanisms that predispose salt-245 sensitive humans to vascular risk by utilizing the Dahl S rat model under normotensive 246 (normal-salt diet) conditions. The major driving force behind the current study stems from the 247 work in Dr. Mattson's laboratory where they reported that maintaining Dahl S rats at weaning 248 on two different standard chow/normal salt diets differentially affected salt-dependent blood 249 pressure and renal injury phenotypes as adults (27) . Specifically, their study demonstrated that 250 the response to a high-salt diet in adult Dahl S rats maintained on AIN-76A diet developed salt-251 dependent hypertension and greater renal injury compared to counterparts weaned on Teklad 252 diet. We did not observe a difference in blood pressure between our Teklad diet and AIN-76A-253 diet groups or a difference in proteinuria. However, it is important to mention that the Teklad 254 diet used in Mattson's study was Teklad 3075S diet; this diet was custom-made for the 255
Mattson study (27). Whereas, our study exploited the widely available Teklad 8604 diet that 256 many institutions, including our own, use as normal rat chow. Our laboratory has a long-257 standing interest in examining vascular NOS function in cardiovascular disease states, thus 258 prompting us to study arterial NOS function in Dahl S rats. 259
Using the non-specific NOS inhibitor, L-NAME, we showed a reduced sensitivity to ACh 260 and increased sensitivity to PE in third-order mesenteric arteries from Teklad, AIN, and 261
Teklad→AIN groups. These data indicate that NOS function is intact in these 3 diet groups; 262 however, NOS function was lost in the AIN→Teklad group. Importantly, the vasorelaxation 263 response to the exogenous NO-donor SNP was similar in all 4 diet groups, indicating the 264 reduced NOS-mediated vasorelaxation in the AIN→Teklad group is not dependent on reduced 265 vascular smooth muscle response to NO. In probing a mechanism for this loss in NOS 266 function, it was observed that both total NOS3 and NOS3-phosphoserine1177 expression were 267 reduced compared to AIN-fed rats. It has been demonstrated that reduced NOS3-p1177 268 expression is associated with reduced NOS3 enzyme activity (1). These data indicate that 269 adaptation to the Teklad diet in adulthood from the AIN weaning diet results in dysfunctional 270 vascular NOS signaling most likely due to reduced NOS3 and NOS3-p1177. Protein kinase 271 B/Akt kinase phosphorylates NOS3 at ser-1177 to increase NOS3 activity (38). We propose 272 that switching adult Dahl S rats to Teklad diet reduces small arterial Akt kinase function. 273 Interestingly, the Teklad→AIN Dahl S rat group demonstrated reduced NOS3 expression 274 whereas phosphorylated NOS3 was greatly enhanced suggesting that switching to AIN diet 275 activates small arterial Akt kinase function. We probed the possible activation status of NOS in 276 the Teklad→AIN by measuring metabolites of bioavailable NO; whereas plasma nitrite was 277 similar in all diet groups, plasma nitrate was increased in the Teklad→AIN diet-switch group 278 with no change in the AIN→Teklad diet-switch group. These data suggest that the 279
Teklad→AIN diet switch but not the AIN→Teklad diet switch may influence bioavailable NO in 280
Dahl S rats. 281
In adult Dahl S rats, basal ACh-mediated vasorelaxation and PE-mediated 282 vasoconstriction in small mesenteric artery segments was not altered by placing rats on 283 different standard chow diets (AIN or Teklad) at weaning or following a diet-switch protocol 284 whereby the 'weaning diets' were switched as adults. Intriguingly, this was evident regardless 285 of the loss of NOS function in the AIN→Teklad diet-switch group. Importantly, small artery 286 vascular reactivity is modulated by NOS-independent mechanisms including endothelium-287 derived hyperpolarizating factors (EDHF) (8, 13, 40) . Scotland et al demonstrated in small 288 mesenteric arteries that EDHF functions to maintain normal vascular reactivity in NOS3 289 knockout mice (39). Future experiments will examine the degree of EDHF function in our Dahl 290
S rat diet-switch groups. 291
Diet switch-induced changes in vascular NOS function and signaling in small arteries 292 from adult Dahl S rats occurred without changes in blood pressure and heart rate or the 293 circadian rhythm of these parameters; rat growth; or body weight. These data suggest that the 294 changes in vascular NOS phenotype detected in our study are specific to the macronutrient 295 composition and/or the source of each macronutrient in the Teklad versus AIN diet. Teklad 296 8604 is a proprietary diet containing 33% protein from soy, fish meal, wheat, corn, yeast, 297 molasses and whey; 53% carbohydrates from corn, wheat, soy molasses, whey, and yeast; 298 and 4% fat derived from soy, corn, wheat and fish. Whereas, AIN-76A is a purified diet 299 composed of 19% protein derived from casein; 69% carbohydrates from corn starch and 300 sucrose; and 12% fat from corn oil and trace amounts from casein. Currently, it is unknown 301 which component in the diet is responsible for the observed change in vascular NOS 302 phenotype; however we speculate that, although the protein in the Teklad diet comes from 303 many sources, the total protein content is higher than in the AIN diet. In Dahl S rats, the 304 consumption of a high-protein diet consisting of 33% protein and normal salt for 8 weeks 305
induces greater vascular injury in the kidney compared to rats on a diet with normal (18%) 306 protein content (12); however, vascular NOS function or expression was not examined in that 307 study. Our present investigation revealed that switching rats weaned on AIN diet, which has a 308 normal protein composition compared to the Teklad diet, to the Teklad diet resulted in loss of 309 NOS function and loss of NOS3 expression and signaling. 310
311
Perspectives 312
Collectively, our current study demonstrates that manipulating the standard 313 chow/normal-salt diet in adult Dahl S rats, which mimic cardiovascular disease progression in 314 salt sensitive humans, differentially affects small artery NOS phenotype. Although the Dahl S 315 rat has been widely used to study mechanisms of high-salt diet-induced cardiovascular 316 disease and NOS dysfunction (2, 4-7, 9, 10, 12, 14, 15, 18, 19, 21-23, 25, 27, 28, 30-37, 41 , 317 46), far fewer studies have examined vascular NOS function or signaling in Dahl S rats 318 maintained on normal-salt diet. Our current data suggests that switching standard chow diets 319 alone may result in enhanced sensitivity to additional cardiovascular insults such as behavioral 320 stressors or a high-salt diet in this rat strain. Our study should encourage investigators to 321 more carefully consider that additional environmental stressors from dietary paradigms may 322 influence the vascular NOS phenotype and therefore the vascular injury risk. 323 324 Na Excretion (mEq/24h) 6.0±0.9 (7) 6.4±0.4 (9) 9.0±1.3 (7) 5.9±0.4 (4) Proteinuria (mg/24h) 0.6±0.1(6) 1.0±0.2(9) 0.7±0.07(6) 0.8±0.06(6)
340
Dahl S rats were given Teklad or AIN standard chow diets at weaning (3 weeks old). At 12 weeks,
341
weaning-diet groups were divided and a subset of rats underwent a diet switch generating two 342 additional diet groups: Teklad→AIN and AIN→Teklad. Number of rats is in parentheses. *P<0.05 vs.
343
Teklad; †P<0.05 vs. Analyzed by two-way ANOVA. Figure 5 
345
